Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 7.37
-1.47 %
$ 399 M
Market Cap
-1.88
P/E
EBS - REVENUE
Revenue EBS - Emergent BioSolutions Inc.
1.05 B
LAST VALUE
-23.49%
2 YEAR CAGR
6.05%
5 YEAR CAGR
12.87%
10 YEAR CAGR